Statistics for Bluebird Bio (id:8087 BLUE)
Valuation metrics
Market cap
64.75M
Enterprise value
321.89M
Trailing P/E (ttm)
-0.18
Forward P/E
-0.51
PEG ratio
-0.51
Price/Sales (ttm)
1.18
Price/Book (mrq)
0.33
Enterprise Value/Revenue
5.86
Enterprise Value/EBITDA
-1.06
Overview
Shares outstanding
193.91M
Float
193.01M
Shares short
47.71M
% Held by insiders
0.01%
% Held by institutions
0.44%
Average volume (10 days)
7.17M
Average volume (90 days)
Price summary
52-Week low
0.29
52-Week high
5.53
52-Week change
-997.14%
Beta
0.80
50-Day moving average
0.49
200-Day moving average
0.91
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
November 05th, 2021
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
-13.66%
Operating margin
-548.98%
Operational effectiveness
Return on assets
-36.24%
Return on equity
-186.70%
Income statement
Revenue (ttm)
0.36
Revenue per share (ttm)
0.36
Quarterly revenue growth (yoy)
Gross profit (ttm)
-4,030,000.00
EBITDA
-302,105,984.00
Net income to common (ttm)
-319,251,008.00
Diluted EPS (ttm)
-2.30
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
144.07M
Total cash per share (mrq)
0.74
Total debt (mrq)
395.64M
Total Debt/Equity (mrq)
746.76
Current ratio (mrq)
68.30%
Book value per share (mrq)
1.01
Cash flow
Cash flow statement
-245,115,008.00
Levered free cash flow (LFCF)
-163,919,632.00